Freelance Writing Jobs | Today's Articles | Sign In

Articles
Writers
 
Browse Sections
Home Reference

Articles related to "Polyadp Ribose Polymerase Ovarian Cancer"


A study presented at the 2009 ASCO meeting, shows the efficiency and low toxicity of a new inhibitor of the PARP protein, in patients resistant to standard chemotherapy.
olaparib azd2281 ku-0059436 ovarian cancer · brca1 brca2 mutation ovarian cancer · hereditary ovarian cancer brca · polyadp-ribose polymerase ovarian cancer · parp brca ovarian cancer


| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9 |